Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,285 | 54 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $380.71 | 4 | $0 (2022) |
| Amgen Inc. | $338.02 | 4 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $294.58 | 4 | $0 (2022) |
| Kestra Medical Technology Services, Inc. | $216.09 | 2 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $214.47 | 3 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $183.58 | 3 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $177.99 | 9 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $175.48 | 3 | $0 (2022) |
| Gilead Sciences, Inc. | $168.38 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $160.55 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $295.71 | 3 | Kestra Medical Technology Services, Inc. ($216.09) |
| 2022 | $619.02 | 6 | Esperion Therapeutics, Inc. ($125.00) |
| 2020 | $300.94 | 7 | Amarin Pharma Inc. ($105.02) |
| 2019 | $583.92 | 9 | PFIZER INC. ($188.27) |
| 2018 | $552.07 | 11 | E.R. Squibb & Sons, L.L.C. ($121.11) |
| 2017 | $933.17 | 18 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($108.49) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/04/2023 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $105.72 | General |
| Category: Cardiology | ||||||
| 03/21/2023 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $110.37 | General |
| Category: Cardiology | ||||||
| 01/24/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $79.62 | General |
| Category: Cardiology | ||||||
| 11/15/2022 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $99.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/18/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $71.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $93.39 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/23/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $109.83 | General |
| Category: DIABETES | ||||||
| 07/26/2022 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $119.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/08/2022 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/07/2020 | Medtronic Vascular, Inc. | Micra (Device) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Pacemakers | ||||||
| 08/05/2020 | Bardy Diagnostics, Inc. | Carnation Ambulatory Monitor (Device) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 05/28/2020 | Bardy Diagnostics, Inc. | Carnation Ambulatory Monitor (Device) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 05/26/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $42.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/25/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $96.59 | General |
| Category: Cardiology | ||||||
| 02/19/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.24 | General |
| Category: Cardiovascular | ||||||
| 01/28/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $105.02 | General |
| Category: Cardiovascular | ||||||
| 11/26/2019 | Janssen Scientific Affairs, LLC | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $104.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/01/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $6.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $104.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/09/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: DIABETES | ||||||
| 09/25/2019 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $87.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/27/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $100.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/15/2019 | Chiesi USA, Inc. | KENGREAL (Drug) | Food and Beverage | Cash or cash equivalent | $15.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/26/2019 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $94.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/22/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $53.81 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,728 | 2,570 | $364,748 | $123,641 |
| 2022 | 21 | 1,771 | 2,876 | $399,780 | $135,984 |
| 2021 | 23 | 2,015 | 3,362 | $432,939 | $150,918 |
| 2020 | 20 | 1,989 | 3,160 | $382,753 | $128,377 |
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 502 | 802 | $118,696 | $67,056 | 56.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 119 | 194 | $33,950 | $10,280 | 30.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 507 | 817 | $77,615 | $8,157 | 10.5% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Office | 2023 | 74 | 103 | $17,510 | $5,603 | 32.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 42 | 57 | $9,975 | $5,222 | 52.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 35 | $8,750 | $4,673 | 53.4% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 41 | 58 | $13,050 | $4,370 | 33.5% |
| 93282 | Programming of single lead implantable defibrillator system | Office | 2023 | 40 | 60 | $10,800 | $3,345 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $4,875 | $3,167 | 65.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 13 | 37 | $2,960 | $1,719 | 58.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 12 | 12 | $13,200 | $1,585 | 12.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 37 | 37 | $18,500 | $1,510 | 8.2% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 27 | 29 | $5,800 | $1,095 | 18.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 18 | 36 | $7,920 | $973.80 | 12.3% |
| 93285 | Programming of cardiac rhythm monitor system | Office | 2023 | 16 | 21 | $2,625 | $928.06 | 35.4% |
| 93291 | Evaluation of cardiac rhythm monitor system | Office | 2023 | 17 | 23 | $2,300 | $851.92 | 37.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 126 | 144 | $3,257 | $829.85 | 25.5% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 15 | 16 | $3,600 | $743.70 | 20.7% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 11 | 11 | $2,145 | $531.62 | 24.8% |
| 93279 | Programming of single lead pacemaker system | Office | 2023 | 11 | 12 | $1,740 | $492.68 | 28.3% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 11 | 11 | $4,400 | $402.16 | 9.1% |
| J0280 | Injection, aminophyllin, up to 250 mg | Office | 2023 | 14 | 14 | $280.00 | $95.30 | 34.0% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 16 | 16 | $800.00 | $8.09 | 1.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 484 | 872 | $129,006 | $74,167 | 57.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 122 | 209 | $36,575 | $11,734 | 32.1% |
About Dr. Mark O'connor, MD
Dr. Mark O'connor, MD is a Clinical Cardiac Electrophysiology healthcare provider based in Toledo, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245232800.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark O'connor, MD has received a total of $3,285 in payments from pharmaceutical and medical device companies, with $295.71 received in 2023. These payments were reported across 54 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,285).
As a Medicare-enrolled provider, O'connor has provided services to 7,503 Medicare beneficiaries, totaling 11,968 services with total Medicare billing of $538,920. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Practice Information
- Specialty Clinical Cardiac Electrophysiology
- Location Toledo, OH
- Active Since 08/12/2005
- Last Updated 02/06/2009
- Taxonomy Code 207RC0001X
- Entity Type Individual
- NPI Number 1245232800
Products in Payments
- XARELTO (Drug) $404.94
- Repatha (Biological) $338.02
- ELIQUIS (Drug) $326.77
- Assure WCD (Device) $216.09
- VYNDAQEL (Drug) $187.29
- JARDIANCE (Drug) $183.58
- LifeVest (Device) $177.99
- Ranexa (Drug) $168.38
- ENTRESTO (Drug) $160.55
- BRILINTA (Drug) $132.60
- NEXLIZET (Drug) $125.00
- ZIO XT Patch (Device) $119.55
- Vascepa (Drug) $105.02
- INVOKANA (Drug) $104.11
- PRALUENT ALIROCUMAB INJECTION (Biological) $100.31
- Impella (Device) $94.52
- SAMSCA (Drug) $90.08
- TR Band (Device) $50.00
- NORTHERA (Drug) $49.18
- FARXIGA (Drug) $42.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Cardiac Electrophysiology Doctors in Toledo
Dr. Ryan Cunnane, M.d, M.D
Clinical Cardiac Electrophysiology — Payments: $270,588
Timothy Phelan, Md, MD
Clinical Cardiac Electrophysiology — Payments: $14,812
Helge Simon, M.d, M.D
Clinical Cardiac Electrophysiology — Payments: $752.30